| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/21/2006 | EP1671541A1 Disinfectant |
| 06/21/2006 | EP1670893A2 Immunogenic hiv compositions and related methods |
| 06/21/2006 | EP1670808A1 Antimicrobial derivatives |
| 06/21/2006 | EP1670796A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/21/2006 | EP1670793A1 Antibacterial agents |
| 06/21/2006 | EP1670510A1 Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis. |
| 06/21/2006 | EP1670496A1 A teicoplanin composition with improved antibiotic activity |
| 06/21/2006 | EP1670490A1 Method for inhibiting bacterial colonisation |
| 06/21/2006 | EP1670448A1 Hcv inhibitiing sulfonamides |
| 06/21/2006 | EP1420646B1 Antimicrobial agent |
| 06/21/2006 | EP1406654A4 Methods for regulating bacteria |
| 06/21/2006 | EP1326895B8 Monoclonal antibodies directed against hepatitis b viruses |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1200094B1 Ophthalmic compositions containing antibiotics and nsaids |
| 06/21/2006 | EP1171583B1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP1042363B1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 06/21/2006 | EP0934416B1 Feline polynucleotide vaccine formula |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | CN1791612A Novel antimicrobial peptides with heparin binding activity |
| 06/21/2006 | CN1791599A 丙型肝炎抑制剂化合物 Hepatitis C inhibitor compounds |
| 06/21/2006 | CN1791432A Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1789395A Tibetan herb dracocephalum heterophyllum essential oil with bacteria inhibiting and/or killing functions |
| 06/21/2006 | CN1789279A Inhibitory peptide of YMDD domain of duck hepatitis-B virus polymerase protein and application thereof |
| 06/21/2006 | CN1789270A Mycotic ingection-resisting fosfluconazole hydrate and preparation method thereof |
| 06/21/2006 | CN1789263A Substituted piperazidine-piperidine amide compound, preparation method and uses thereof |
| 06/21/2006 | CN1789250A Optical antimer of a group of nitro imidazole derivatives, preparation method and uses thereof |
| 06/21/2006 | CN1788781A Phosphoric acid Chinese traditional medicine compound preparation for preventing and treating bacterial and viral infection of fowl and livestock, and preparation method thereof |
| 06/21/2006 | CN1788778A Medicine for treating hepatitis and its preparing process |
| 06/21/2006 | CN1788744A Ciliate desert-grass effective parts formulation resin processing method |
| 06/21/2006 | CN1788734A Selenium sulfide nano particle additive preparing method and use |
| 06/21/2006 | CN1788732A Use of kutkin I in preparing drug for treating hepatitis B, its formulation and preparation method |
| 06/21/2006 | CN1788729A Pharmaceutical composition containing nevirapine and valproic acid or its salt |
| 06/21/2006 | CN1788728A Compound oral liquid and suspensoid containing brufen for treating cold |
| 06/21/2006 | CN1788727A Compound dispersion tablet containing brufen for treating cold |
| 06/21/2006 | CN1788725A Voriconazole freeze-drying powder injection and its preparation process |
| 06/21/2006 | CN1788724A Use of geldanamycin ú¿C-3559ú®in preparing drug for herpesvirus genital tract affection |
| 06/21/2006 | CN1260353C Preparation method of polyvalent bacteriophage for treatment of bacterial infections |
| 06/21/2006 | CN1260346C Animal papilla disinfectants and method for improving microbial environment which harmful to animal |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260218C PDF enzyme inhibitor-hydroxamic acid serial compounds, synthetic method and use thereof |
| 06/21/2006 | CN1259968C Medication for preventing and curing AIDS and preparation method |
| 06/21/2006 | CN1259948C External-applying treating liquid for rhinitis and common cold, and its preparation method thereof |
| 06/21/2006 | CN1259929C Anti-virus medicine |
| 06/21/2006 | CN1259925C Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 06/21/2006 | CN1259921C New medicine for treating beriberi |
| 06/21/2006 | CN1259920C Biologically active agents and drugs |
| 06/21/2006 | CN1259917C Cefixime pharmaceutical composition for injection |
| 06/21/2006 | CN1259916C Preparation process of antifungal itraconazole containing freeze dried powder injection and transfusion |
| 06/21/2006 | CN1259905C Use of Rhizoma-Curcumae-Longae element in preparing medicine for treating lung disease |
| 06/20/2006 | US7064220 Production of furanones |
| 06/20/2006 | US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 06/20/2006 | US7064198 For treating human/animal gram-positive/negative bacteria infections |
| 06/20/2006 | US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064139 Prevention reproduction of virus |
| 06/20/2006 | US7064133 A 2-carbamoyl-8-hydroxyquinoline-7-carboxylic acid compound or its salt, e.g., 2-(3,4-dihydroxybenzylcarbamoyl)-8-hydroxyquinoline-7-carboxylic acid or its sodium salt, useful as a retrovirus integrase inhibitor, especially for treatment of HIV |
| 06/20/2006 | US7064109 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 06/20/2006 | US7063860 Bladder therapy; antiinflammatory agents |
| 06/20/2006 | US7063849 Use of HIV-1 gp120 and gp160 proteins modified in the v3 loop for the preparation of vaccine compositions and formulations containing the same |
| 06/20/2006 | US7063835 Virus strains |
| 06/20/2006 | US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors |
| 06/20/2006 | US7063831 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/20/2006 | CA2350943C Process for the manufacture of liquid filled capsules |
| 06/20/2006 | CA2220103C Composition comprising amoxycillin and clavulanic acid |
| 06/20/2006 | CA2127700C Marek's disease virus recombinant poxvirus vaccine |
| 06/15/2006 | WO2006062438A1 Method for treating respiratory diseases of cattle |
| 06/15/2006 | WO2006062434A1 Modified 5'- phosphonate azidothymidine-potential anti-viral preparations |
| 06/15/2006 | WO2006061714A2 Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| 06/15/2006 | WO2006061585A1 Pyrrolidine compounds |
| 06/15/2006 | WO2006061217A2 Saquinavir derivatives useful in immunoassay |
| 06/15/2006 | WO2006060969A1 Peptides which mimic the antigenic regions of the hepatitis a virus |
| 06/15/2006 | WO2006060920A1 Novel uses of egf |
| 06/15/2006 | WO2006060903A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | WO2006044968A3 Combination therapy for treating viral infections |
| 06/15/2006 | WO2006044573A3 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/15/2006 | WO2006044379A3 Novel curcumin analogues and uses thereof |
| 06/15/2006 | WO2006042479A9 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 06/15/2006 | WO2006042324A3 Antifungal composition applicable to body tissue, preferably nails |
| 06/15/2006 | WO2006007662A8 Methods for increasing foam stability |
| 06/15/2006 | WO2005007683A8 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128811 Hydroxamic acid- and N-formyl hydroxylamine hydrazide derivatives; veterinary medicine |
| 06/15/2006 | US20060128804 Novel approach to antimicrobial host defense with molecular shields with EPA and DHA analogs |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis |
| 06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
| 06/15/2006 | US20060128692 Non nucleoside reverse transcriptase inhibitors |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms |
| 06/15/2006 | US20060128656 Charged phospholipid compositions and methods for their use |